APhA Pain Institute 2020: Healing Body and Mind: Mental Health Comorbidities in Substance Use Disorder

This event will occur on Thursday, March 19, 2020, from 8:00 am to 5:30 pm at National Harbor, MD.

Activity Preview

The connection is too common: Approximately 50% of all people who experience a mental illness will struggle with substance misuse as well. Research shows that substance misuse co-occurs at a high prevalence with various mental disorders, from depression and ADHD to borderline personality disorder.

As frontline practitioners, pharmacists are well positioned to take notice—and take action. At APhA Pain Institute 2020, pharmacists will examine the link between substance misuse and mental health and explore how and when to intervene.

Sessions cover the difficulty of overcoming two stigmas, the merits of syringe service programs, and ways to start tough conversations. A special guest, a survivor of a suicide attempt related to opioid misuse, will share ways attendees can identify and address suicidality in their own patients.

Agenda

Access agenda here.

Registration Information

  • Pre-registration is required. The registration fee is $349 for APhA members and $399 for non-members.
  • Lunch voucher (choose your own lunch venue in National Harbor)

    SAVE $100 in 2 easy steps:

    1. Register for APhA2020.

    2. Register for the APhA Pain Institute 2020: Healing Body and Mind: Mental Health Comorbidities in Substance Use Disorder by selecting “Add to Cart” above.

    All registration cancellations must be in writing to the APhA InfoCenter. Cancellations received by February 21, 2020, will be refunded less a $100 administrative fee. No refunds will be made for cancellations received after February 21, 2020. Ticketed event fees are non-refundable except when an event is canceled by APhA.

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education (CPE). ACPE information coming soon. 

To obtain CPE credit for any of the program’s sessions, Learners must pre-register online, participate in the session(s), complete the evaluation for each session, and claim credit for each. An attendance code and further instructions will be provided during each session. In order to complete the online activity evaluation form, participants will need to have a valid pharmacist.com username and password. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript. 

*The deadline to claim credit for attending the live sessions is April 19, 2020.*

Learning Level: 2

Activity Type: Application-based

Target Audience: Pharmacists

Development

APhA Pain Institute 2020: Healing Body and Mind: Mental Health Comorbidities in Substance Use Disorder is a live continuing education activity for pharmacists developed by the American Pharmacists Association.

Disclosures

Speaker disclosures will be provided during the presentation of each session. 

APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, please visit the APhA website at www.pharmacist.com/apha-disclosures.

Conflicts of interest have been resolved through content review by Helen Sairany, PharmD, BCACP, MBA, Associate Director of Content Development at the American Pharmacists Association.

Live Sessions

Substance Use Disorders and Mental Health Disorders: How You Can Help

This session explores the many connections and concerns and gives you proven tactics for helping your patients.

At the completion of this knowledge-based activity, participants will be able to
1. Describe the commonality and connection of mental health conditions and substance use disorders.
2. Evaluate the impact of adverse childhood experiences in the development of substance use disorders and mental health disorders.
3. Discuss the risk of developing mental health conditions in patients with substance use disorders.
4. Discuss the biological and psychological causes of misusing substances in patients with mental health conditions.
5. Describe how pharmacists can use their understanding of the connection between mental health conditions and substance use disorders to assist patients who are in recovery or struggling with the disease of addiction.

The Sickness of Shame: Healing the Wounds of Substance Use Disorders

Hear from a leading expert on the many types of shame, strategies to prevent unhealthy shame during substance use disorder recovery, and how to apply this knowledge for your patients.

At the completion of this knowledge-based activity, participants will be able to
1. Distinguish among the following terms: healthy shame, unhealthy shame, guilt, and stigma.
2. Explain how feelings related to shame can impact the treatment of substance use disorders and the recovery process.
3. Describe how pharmacists can use the principles of healthy and unhealthy shame to assist patients who are in recovery or struggling with substance use disorders.

59 ½ Minutes Cover Story: Suicide, Substance Use, and Survival

Join us for this 60 Minutes–style profile, in which a suicide survivor sheds light on the many symptoms he experienced when misusing substances and the role misuse played in his suicide attempt.

At the completion of this knowledge-based activity, participants will be able to

1. Identify risk factors and protective factors for suicide.
2. Discuss the role of substance misuse in suicidal thoughts and attempts.
3. Select appropriate phrasing and reflective responses to include when speaking to a patient about substance misuse and suicide.

Rally Your Dream Team to Prevent Diversion

At this session, you’ll hear success stories from pharmacists who reduced diversion rates with teamwork. They’ll share strategies to support safe and effective pain management with collaboration at the center.

At the completion of this knowledge-based activity, participants will be able to
1. Discuss examples of collaborative models by pharmacists that have prevented opioid diversion.
2. Identify barriers that pharmacists must overcome to build relationships with members of the health care team to reduce rates of diversion.
3. Summarize effective approaches for pharmacists to take when collaborating with members of the health care team.

59 ½ Minutes Feature: Tough Talk about Substance Misuse

In this 60 Minutes–type special, you’ll hear from a behavioral health clinician and primary care specialist who examine the many faces of substance use disorder. You’ll learn strategies for screening, destigmatizing the condition, and starting those difficult but necessary conversations.

At the completion of this application-based activity, participants will be able to

1. Describe the patient’s perspective of the experience of substance use disorder.
2. Use effective communication skills to destigmatize substance use disorder.
3. Discuss strategies for pharmacists to screen for substance use disorder.
4. Demonstrate how pharmacists can engage in effective conversations with patients who have a substance use disorder.

Syringe Service Programs: Boon or Bane for Communities?

So, who’s right? And what can pharmacists do if they work in a more restrictive state? Don’t miss this timely session to hear the experts lay out their best arguments.

At the completion of this knowledge-based activity, participants will be able to

1. Summarize the data on the impact of syringe service programs (SSPs) on harm reduction.
2. Discuss the role of pharmacy-based nonprescription syringe sales in reducing risk behaviors among people who inject drugs.
3. Identify barriers to implementing SSPs in community pharmacies and strategies to overcome those barriers.
4. Demonstrate skills for pharmacists to navigate difficult conversations with patients about safer syringe use and harm reduction.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

*For more information, contact Pat Szybist at pszybist@aphanet.org.